Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of Leukocytes01:27

Disorders of Leukocytes

2.5K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.5K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K
Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

5
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
5

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Novel CIP2A and BCL-XL Clinical Diagnostic Toolkit to Predict Disease Progression and Treatment-Free Remission in Chronic Myeloid Leukaemia.

International journal of molecular sciences·2026
Same author

Introducing a prognostic score for successful treatment-free remission in chronic myeloid leukaemia.

British journal of haematology·2026
Same author

Pregnancy after hematopoietic stem cell transplant: an international multicenter study.

Blood advances·2026
Same author

Corrigendum to "Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group" [Modern Pathology. 2024;37(2):100406].

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia.

EJHaem·2025
Same author

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Leukemia·2025

相关实验视频

Updated: Apr 19, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K

慢性骨髓性白血病 慢性骨髓性白血病

Jane F Apperley1

  • 1Department of Haematology, Imperial College London, London, UK.

Lancet (London, England)
|December 9, 2014
PubMed
概括

慢性髓性白血病 (CML) 现在可以通过口服药物治疗,提供正常寿命. 对CML病原和向治疗的持续研究可能会导致治愈和推进其他癌症治疗方法.

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 分子生物学分子生物学

背景情况:

  • 慢性髓性白血病 (CML) 是一种具有不良预后的致命疾病.
  • 了解分子病原学的进步彻底改变了CML治疗.
  • 有针对性的疗法已经将CML从致命疾病转变为可管理的慢性疾病.

研究的目的:

  • 总结当前对慢性髓性白血病的理解和治疗.
  • 讨论CML的分子基础,诊断,监测和治疗.
  • 探索通过持续的不可检测疾病来实现CML治愈的潜力.

主要方法:

  • 审查CML表现,病理生理学和诊断技术.
  • 分析当前和新兴的治疗选择,包括向口服药物.
  • 讨论治疗副作用,患者的治疗结果和监测策略.

主要成果:

  • 慢性肌痛性淋巴瘤的预后有了显著的改善,患者现在可以在口服药物治疗下达到正常寿命.
  • 由分子洞察力驱动的有针对性的疗法是非常有效的.
  • 正在研究实现治愈的可能性 (稳定不检测到的疾病脱离药物治疗).

更多相关视频

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.8K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

31.2K

相关实验视频

Last Updated: Apr 19, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.8K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

31.2K

结论:

  • 终身口服向治疗已经将CML转化为一种可管理的疾病,预期寿命正常.
  • ML研究为了解白血病发生和开发其他恶性瘤的治疗方法提供了一个模型.
  • 实验室研究迅速转化为CML的临床应用,为瘤学加速进步提供了希望.